London, United Kingdom – 22nd May, 2025 Axis-MedTech is pleased to announce that we have secured for our Ablatus Limited subsidiary the assets, goodwill, intellectual property and associated knowhow of Ablatus Therapeutics.
About Ablatus Ltd
Ablatus Ltd specialise in Dual-Modality Tissue Ablation. A novel, non-thermal ablation technology that combines electrical and chemical energy to treat soft tissue tumours with greater precision and safety.
Unlike conventional thermal ablation methods, this dual-modality approach avoids collateral damage to surrounding structures, making it ideal for complex or previously inoperable cases.
The platform is poised to address unmet needs in oncology, particularly for hard-to-reach or temperature-sensitive treatment zones.
Geoffrey Miller, Axis-MedTech Chairman commented “we are delighted to have completed our first transaction and look forward to taking the business through to fulfil its promise.
This transaction aligns seamlessly with Axis-MedTech's long-term strategy by reinforcing its commitment to identifying and developing high-potential medical technologies that can drive meaningful advancements in patient care.
Axis-MedTech was founded on the principle of addressing structural inefficiencies in the Life Sciences sector - particularly by acquiring businesses with strong intellectual property but limited strategic or financial resources. The addition of Ablatus Ltd reflects this vision, as its dual-modality tissue ablation technology represents a highly innovative approach to treating complex soft tissue tumours with greater precision and safety.
By integrating Ablatus Ltd’s assets and expertise, Axis-MedTech can accelerate the commercialisation of this groundbreaking technology while ensuring robust corporate governance, strategic oversight, and disciplined capital management. This transaction also signals Axis-MedTech’s intent to build a portfolio of high-impact health and wellness
companies with global relevance, ultimately positioning itself as a leader in medical innovation”.
About Axis-MedTech
Axis-MedTech was established to address a structural inefficiency within the Life Sciences sector - where ground-breaking innovation and entrepreneurial energy often outpace the development of the strategic frameworks needed to support long-term growth. This dynamic presents a significant opportunity to contribute positively to the ecosystem by providing the guidance, resources, and operational support that can help promising ventures reach their full potential. In today’s environment, Axis-MedTech sees an opportunity to partner with companies that possess exceptional intellectual property but may benefit from enhanced strategic alignment and capital stewardship. Through thoughtful collaboration and the application of decades of proven management expertise, Axis aims to unlock value, empower key innovators, and build a portfolio of globally impactful health and wellness businesses - for the benefit of all stakeholders.
Contact : Geoff.miller@axis-medtech.com
